Trevena, Inc. (NASDAQ:TRVN – Get Rating) was the target of a large decrease in short interest in the month of May. As of May 31st, there was short interest totalling 441,900 shares, a decrease of 41.3% from the May 15th total of 752,700 shares. Based on an average trading volume of 2,780,000 shares, the short-interest […]
Trevena, Inc. (NASDAQ:TRVN – Get Rating) was the recipient of a large drop in short interest during the month of May. As of May 31st, there was short interest totalling 441,900 shares, a drop of 41.3% from the May 15th total of 752,700 shares. Based on an average daily trading volume, of 2,780,000 shares, the […]
StockNews.com assumed coverage on shares of Trevena (NASDAQ:TRVN – Get Rating) in a research report sent to investors on Friday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. A number of other analysts also recently issued reports on the company. HC Wainwright cut their price objective on Trevena from $11.00 to […]
Equities researchers at StockNews.com began coverage on shares of Trevena (NASDAQ:TRVN – Get Rating) in a research report issued on Friday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Several other research analysts have also issued reports on TRVN. JMP Securities reissued a “market outperform” rating and issued a $2.00 price target […]
StockNews.com initiated coverage on shares of Trevena (NASDAQ:TRVN – Get Rating) in a report published on Thursday. The firm issued a sell rating on the biopharmaceutical company’s stock. A number of other analysts also recently weighed in on TRVN. JMP Securities restated a market outperform rating and issued a $2.00 target price on shares of […]